{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:39Z","timestamp":1786118799776,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Myeloid sarcoma and blastic plasmacytoid dendritic cell neoplasm (BPDCN) are hematologic malignancies of immature cells that frequently involve the skin. In the absence of bone marrow involvement or an associated myeloid neoplasm, distinguishing myeloid sarcoma with disseminated cutaneous involvement (leukemia cutis) from BPDCN is particularly challenging because of overlapping clinical and immunophenotypic features. We report a case of NPM1-mutated myeloid sarcoma presenting with rapidly progressive cutaneous lesions and no initial medullary disease, resulting in an initial misdiagnosis of BPDCN and treatment accordingly. The clinicopathologic evolution over an 8-month period is detailed through analysis of 8 skin biopsies and 5 bone marrow examinations. The disease ultimately progressed to refractory acute myeloid (monoblastic) leukemia, and the patient died approximately 8 months after initial presentation.<\/jats:p>","DOI":"10.1097\/dad.0000000000003205","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T21:00:29Z","timestamp":1767128429000},"page":"221-225","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["NPM1-Mutated Myeloid Sarcoma\/Leukemia Cutis Mimicking Blastic Plasmacytoid Dendritic Cell Neoplasm and Heralding Bone Marrow Acute Myeloid Leukemia"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4997-847X","authenticated-orcid":false,"given":"Aileen Y.","family":"Hu","sequence":"first","affiliation":[{"name":"Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX;"},{"name":"Department of Pathology, Albany Medical College, Albany, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Jorgensen","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadharsini","family":"Nagarajan","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Leventaki","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Torres-Cabala","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.5858\/arpa.2016-0504-CP","article-title":"Initial diagnostic workup of acute leukemia: guideline from the College of American Pathologists and the American Society of Hematology","volume":"141","author":"Arber","year":"2017","journal-title":"Arch Pathol Lab Med."},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1186\/s12885-019-6357-y","article-title":"Clinical and imaging features of myeloid sarcoma: a German multicenter study","volume":"19","author":"Meyer","year":"2019","journal-title":"BMC Cancer"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/s41375-022-01538-9","article-title":"Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients","volume":"36","author":"Khanlari","year":"2022","journal-title":"Leukemia"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1182\/bloodadvances.2019000647","article-title":"How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?","volume":"3","author":"Garnache-Ottou","year":"2019","journal-title":"Blood Adv."},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"837","DOI":"10.5858\/arpa.2021-0612-RA","article-title":"An analysis of the pathologic features of blastic plasmacytoid dendritic cell neoplasm based on a comprehensive literature database of cases","volume":"147","author":"Ohgami","year":"2023","journal-title":"Arch Pathol Lab Med."},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3109\/10428194.2014.963080","article-title":"Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis","volume":"56","author":"Movassaghian","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/2643-3230.BCD-23-0144","article-title":"Criteria for diagnosis and molecular monitoring of NPM1-mutated AML","volume":"5","author":"Falini","year":"2024","journal-title":"Blood Cancer Discov."},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/modpathol.2013.238","article-title":"Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm","volume":"27","author":"Sangle","year":"2014","journal-title":"Mod Pathol."},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"105766","DOI":"10.1016\/j.humpath.2025.105766","article-title":"Investigation of NPM1 mutation frequency in cutaneous blastic plasmacytoid dendritic cell neoplasms","volume":"158","author":"Hamdan","year":"2025","journal-title":"Hum Pathol."},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"100253","DOI":"10.1016\/j.modpat.2023.100253","article-title":"Comparison and development of immunohistochemical diagnostic criteria for blastic plasmacytoid dendritic cell neoplasm","volume":"36","author":"Sakamoto","year":"2023","journal-title":"Mod Pathol."},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.18632\/oncotarget.2223","article-title":"Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm","volume":"5","author":"Stenzinger","year":"2014","journal-title":"Oncotarget"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"1325431","DOI":"10.3389\/fonc.2024.1325431","article-title":"Genetic alterations in myeloid sarcoma among acute myeloid leukemia patients: insights from 37 cohort studies and a meta-analysis","volume":"14","author":"Untaaveesup","year":"2024","journal-title":"Front Oncol."},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1038\/s41598-022-10831-7","article-title":"Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci Rep."},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"100352","DOI":"10.1016\/j.modpat.2023.100352","article-title":"Cutaneous manifestations of myeloid neoplasms exhibit broad and divergent morphologic and immunophenotypic features but share ancestral clonal mutations with bone marrow","volume":"37","author":"Sadigh","year":"2024","journal-title":"Mod Pathol."},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/cncr.33458","article-title":"De novo acute myeloid leukemia: a population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017","volume":"127","author":"Sasaki","year":"2021","journal-title":"Cancer"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MOH.0000000000000571","article-title":"Myeloid sarcoma","volume":"27","author":"Shahin","year":"2020","journal-title":"Curr Opin Hematol."},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6004\/jnccn.2023.7026","article-title":"Blastic plasmacytoid dendritic cell neoplasm","volume":"21","author":"Jain","year":"2023","journal-title":"J Natl Compr Cancer Netw."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:46:23Z","timestamp":1786034783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003205","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}